SpringWorks Therapeutics, Inc. logo

SpringWorks Therapeutics, Inc.

NASDAQ:SWTX

Overview | Financials
Company Name SpringWorks Therapeutics, Inc.
Symbol SWTX
Currency USD
Price 35.35
Market Cap 2,625,550,550
Dividend Yield 0%
52-week-range 18 - 53.92
Industry Biotechnology
Sector Healthcare
CEO Mr. Saqib Islam J.D.
Website https://www.springworkstx.com

An error occurred while fetching data.

About SpringWorks Therapeutics, Inc.

SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also developing mirdametinib,

Related Stocks

Apollo Medical Holdings, Inc. logo

Apollo Medical Holdings, Inc.

AMEH

40.82 USD

BioCryst Pharmaceuticals, Inc. logo

BioCryst Pharmaceuticals, Inc.

BCRX

8.15 USD

Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc.

AUPH

7.2 USD

Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc.

FLGT

22.89 USD

Financials

Numbers are in millions USD

Numbers are in millions USD